IntegraGen
Genomics sequencing data interpretation
- B2B
About IntegraGen
Specializes in genomics of cancer and rare genetic diseases, providing DNA sequencing services and genomic data interpretation software for research institutes.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Évry, Île-de-France, France
- Revenue
- €5MFY2025, publicly reported
- Website
- integragen.com
- linkedin.com/company/integragen
IntegraGen in the news
- En bref : Novo, Ipsen, IntegraGen, Maat Pharma, Biomunex, Samsung Biologics
Several companies are making significant business moves, with Novo Nordisk rebranding, Ipsen considering a US plant, IntegraGen facing takeover bids, Maat Pharma's drug rejected, and Biomunex entering Phase I trials.
- Integragen : deux propositions de reprise...
IntegraGen, a genomics company in judicial recovery, has received two takeover bids from Health In Code and ABL Diagnostics for its assets and activities.
- Deux offres de reprise déposées pour IntegraGen
Biotechnology company IntegraGen received two takeover offers from Health In Code and ABL Diagnostics as part of its receivership proceedings.
- Integragen : deux propositions de reprise...
IntegraGen, a genomics company in receivership, has received two takeover bids from Health In Code and ABL Diagnostics, with a court decision expected in October 2026.
- Deux offres de reprise déposées pour IntegraGen
Two confidential takeover bids have been submitted for IntegraGen's assets, potentially leading to delisting and no shareholder value.
IntegraGen at a glance
IntegraGen is a B2B company in the Biotechnology Research industry, headquartered in Évry, Île-de-France, France.
IntegraGen has 11–50 employees.
IntegraGen's revenue is €5M (FY2025, publicly reported).
Selling to companies like IntegraGen?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies